Page last updated: 2024-09-05

bd 1047 and muromonab-cd3

bd 1047 has been researched along with muromonab-cd3 in 1 studies

Compound Research Comparison

Studies (bd 1047)	Trials (bd 1047)	Recent Studies (post-2010) (bd 1047)	Studies (muromonab-cd3)	Trials (muromonab-cd3)	Recent Studies (post-2010) (muromonab-cd3)
118	0	54	85	1	50

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Prendergast, MA; Reynolds, AR; Saunders, MA	1

Other Studies

1 other study(ies) available for bd 1047 and muromonab-cd3

Article	Year
Ethanol Stimulates Endoplasmic Reticulum Inositol Triphosphate and Sigma Receptors to Promote Withdrawal-Associated Loss of Neuron-Specific Nuclear Protein/Fox-3. Alcoholism, clinical and experimental research, 2016, Volume: 40, Issue:7 Topics: Animals; Antigens, Nuclear; Endoplasmic Reticulum; Ethanol; Ethylenediamines; Female; Hippocampus; Inositol Phosphates; Macrocyclic Compounds; Male; Nerve Tissue Proteins; Oxazoles; Rats; Receptors, sigma; Substance Withdrawal Syndrome	2016

Article

Year

Ethanol Stimulates Endoplasmic Reticulum Inositol Triphosphate and Sigma Receptors to Promote Withdrawal-Associated Loss of Neuron-Specific Nuclear Protein/Fox-3.

Alcoholism, clinical and experimental research, 2016, Volume: 40, Issue:7

Topics: Animals; Antigens, Nuclear; Endoplasmic Reticulum; Ethanol; Ethylenediamines; Female; Hippocampus; Inositol Phosphates; Macrocyclic Compounds; Male; Nerve Tissue Proteins; Oxazoles; Rats; Receptors, sigma; Substance Withdrawal Syndrome

2016